Search

Results: 6

Cover Image for Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2

Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2

Ray K Iles, Raminta Zmuidinaite, Jason K Iles, George Carnell, Alex Sampson, Jonathan L Heeney

Dec 14, 2020

The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus has stretched national testing capacities to breaking points in almost all countries of the world. The need to rapidly screen vast numbers of a country's population in...

covid-19 MALDI-ToF MS SARS-CoV-2 Biosecurity diagnostic test screening

Published by:

Cover Image for A How to Guide

Ray K Iles, Jason K Iles, Raminta Zmuidinaite, Michael Roberts

Oct 06, 2022

Review covid-19 SARS-CoV-2 viral infection detection asymptomatic screening MALDI-ToF MS CLIA-LDT clinical process

Published by:

Cover Image for A How to Guide

Ray K Iles, Jason K Iles, Raminta Zmuidinaite, Michael Roberts

Oct 24, 2022

Applying MALDI-ToF mass spectrometry as a clinical diagnostic test for viruses is different from that of bacteria, fungi and other micro-organisms. This is because the systems biology of viral infections, the size and chemical...

CLIA-LDT covid-19 MALDI-ToF MS SARS-CoV-2 asymptomatic screening clinical process detection viral infection Bacteria covid-19 Humans Spectrometry Mass Matrix-Assisted Laser Desorption-Ionization Viral Proteins Virus Diseases viruses

Published by:

Cover Image for Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity.

Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity.

Ray K Iles, Jason K Iles, Jonathan Lacey, Anna Gardiner, Raminta Zmuidinaite

Nov 04, 2022

article covid-19 MALDI-ToF MS Plasma glycated albumin glycovariant/glycated IgG3

Published by:

Cover Image for Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2

Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2

Ray K. Iles, Raminta Zmuidinaite, Jason K. Iles, George Carnell, Alex Sampson, Jonathan L. Heeney

Sep 25, 2020

The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus has stretched national testing capacities to breaking points in almost all countries of the world. The need to rapidly screen vast numbers of a country’s population in...

Biosecurity covid-19 SARS-CoV-2 screening diagnostic test MALDI-ToF MS

Published by:

Cover Image for Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity.

Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity.

Ray K Iles, Jason K Iles, Jonathan Lacey, Anna Gardiner, Raminta Zmuidinaite

Nov 15, 2022

covid-19 MALDI-ToF MS glycated albumin glycovariant/glycated IgG3 Plasma

Published by: